Age, waist circumference, and blood pressure are associated with skin microvascular flow motion: The Maastricht Study

Journal of Hypertension

Volumn 32, Issue 12, 2014, Pages 2439-2449

  Muris, Dennis M J ^a,b   Houben, Alfons J H M ^a,b   Kroon, Abraham A ^a,b   Henry, Ronald M A ^a,b   Van Der Kallen, Carla J H ^a,b   Sep, Simone J S ^a,b   Koster, Annemarie ^c,d   Dagnelie, Pieter C ^d   Schram, Miranda T ^a,b   Stehouwer, Coen D A ^a,b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Blood flow regulation; Microcirculation; Risk factors

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; FEMALE; FOURIER TRANSFORMATION; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; LASER DOPPLER FLOWMETRY; MALE; MEAN ARTERIAL PRESSURE; MICROVASCULARIZATION; MIDDLE AGED; NORMAL HUMAN; POPULATION; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE; SKIN BLOOD FLOW; SKIN MICROVASCULAR FLOW MOTION; SMOKING; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; BLOOD FLOW; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; HYPERTENSION; MICROCIRCULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; RISK FACTOR; SKIN; VASCULARIZATION;

BLOOD PRESSURE; CARDIOVASCULAR DISEASES; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERTENSION; LASER-DOPPLER FLOWMETRY; MALE; MICROCIRCULATION; MIDDLE AGED; PROSPECTIVE STUDIES; REGIONAL BLOOD FLOW; RISK FACTORS; SKIN; WAIST CIRCUMFERENCE;

EID: 84927784001     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000000348     Document Type: Article

References (48)

1. Jonk AM, Houben AJ, Schaper NC, de Leeuw PW, Serne EH, Smulders YM, Stehouwer CD. Meal-related increases in microvascular vasomotion are impaired in obese individuals: a potential mechanism in the pathogenesis of obesity-related insulin resistance. Diabetes Care 2011; 34 (Suppl 2):S342-S348.
2. Rattigan S, Clark MG, Barrett EJ. Hemodynamic actions of insulin in rat skeletal muscle: evidence for capillary recruitment. Diabetes 1997; 46:1381-1388.
3. Thorn CE, Kyte H, Slaff DW, Shore AC. An association between vasomotion and oxygen extraction. Am J Physiol Heart Circ Physiol 2011; 301:H442-449.
4. Ursino M, Cavalcanti S, Bertuglia S, Colantuoni A. Theoretical analysis of complex oscillations in multibranched microvascular networks. Microvasc Res 1996; 51:229-249.
5. Intaglietta M. Vasomotion and flowmotion: physiological mechanisms and clinical evidence. Vasc Med 1990; 1:101-112.
6. Slaaf DW, Vrielink HH, Tangelder GJ, Reneman RS. Effective diameter as a determinant of local vascular resistance in presence of vasomotion. Am J Physiol 1988; 255:H1240-H1243.
7. Schmidt-Lucke C, Borgstrom P, Schmidt-Lucke JA. Low frequency flowmotion/(vasomotion) during patho-physiological conditions. Life Sci 2002; 71:2713-2728.
8. Aalkjaer C, Boedtkjer D, Matchkov V. Vasomotion: what is currently thought? Acta Physiol (Oxf) 2011; 202:253-269.
9. Kvandal P, Stefanovska A, Veber M, Kvernmo HD, Kirkeboen KA. Regulation of human cutaneous circulation evaluated by laser Doppler flowmetry, iontophoresis, and spectral analysis: importance of nitric oxide and prostaglandines. Microvasc Res 2003; 65:160-171.
10. Stefanovska A, Bracic M, Kvernmo HD. Wavelet analysis of oscillations in the peripheral blood circulation measured by laser Doppler technique. IEEE Trans Biomed Eng 1999; 46:1230-1239.
11. Manson JE, Nathan DM, Krolewski AS, Stampfer MJ, Willett WC, Hennekens CH. A prospective study of exercise and incidence of diabetes among US male physicians. JAMA 1992; 268:63-67.
12. Muris DM, Houben AJ, Schram MT, Stehouwer CD. Microvascular dysfunction is associated with a higher incidence of type 2 diabetes mellitus: a systematic review and meta-analysis. Arterioscler Thromb Vasc Biol 2012; 32:3082-3094.
13. de Jongh RT, Serne EH, IJzerman RG, de Vries G, Stehouwer CD. Impaired microvascular function in obesity: implications for obesity-associated microangiopathy, hypertension, and insulin resistance. Circulation 2004; 109:2529-2535.
14. Muris DM, Houben AJ, Schram MT, Stehouwer CD. Microvascular dysfunction: an emerging pathway in the pathogenesis of obesityrelated insulin resistance. Rev Endocr Metab Disord 2013; 14:29-38.
15. Benbow SJ, Pryce DW, Noblett K, MacFarlane IA, Friedmann PS, Williams G. Flow motion in peripheral diabetic neuropathy. Clin Sci (Lond) 1995; 88:191-196.
16. de Jongh RT, Serné EH, IJzerman RG, Jørstad HT, Stehouwer CD. Impaired local microvascular vasodilatory effects of insulin and reduced skin microvascular vasomotion in obese women. Microvasc Res 2008; 75:256-262.
17. Stansberry KB, Shapiro SA, Hill MA, McNitt PM, Meyer MD, Vinik AI. Impaired peripheral vasomotion in diabetes. Diabetes Care 1996; 19:715-721.
18. Rossi M, Bradbury A, Magagna A, Pesce M, Taddei S, Stefanovska A. Investigation of skin vasoreactivity and blood flow oscillations in hypertensive patients: effect of short-term antihypertensive treatment. J Hypertens 2011; 29:1569-1576.
19. Rossi M, Carpi A, Di Maria C, Galetta F, Santoro G. Absent postischemic increase of blood flowmotion in the cutaneous microcirculation of healthy chronic cigarette smokers. Clin Hemorheol Microcirc 2007; 36:163-171.
20. Schram MT, Sep SJ, Kallen van der CJ, Dagnelie PC, Koster A, Schaper NC, et al. The Maastricht Study: an extensive phenotyping study on determinants of type 2 diabetes, its complications and its comorbidities. Eur J Epid 2014; 29:439-451.
21. Braverman IM, Schechner JS, Silverman DG, Keh-Yen A. Topographic mapping of the cutaneous microcirculation using two outputs of laser- Doppler flowmetry: flux and the concentration of moving blood cells. Microvasc Res 1992; 44:33-48.
22. Kvandal P, Landsverk SA, Bernjak A, Stefanovska A, Kvernmo HD, Kirkeboen KA. Low-frequency oscillations of the laser Doppler perfusion signal in human skin. Microvasc Res 2006; 72:120-127.
23. Pencina MJ, D'Agostino RB Sr, Larson MG, Massaro JM, Vasan RS. Predicting the 30-year risk of cardiovascular disease: the framingham heart study. Circulation 2009; 119:3078-3084.
24. WHO. Definition and Diagnosis of diabetes mellitus and intermediate hyperglycemia; 2006. www.who.int/diabetes/publications/Definition%20and%20diagnosis%20of%20diabetes-new.pdf.
25. O'Brien E, Coats A, Owens P, Petrie J, Padfield PL, Littler WA, et al. Use and interpretation of ambulatory blood pressure monitoring: recommendations of the British hypertension society. BMJ 2000; 320:1128-1134.
26. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42:1206-1252.
27. Boulton AJ, Malik RA, Arezzo JC, Sosenko JM. Diabetic somatic neuropathies. Diabetes Care 2004; 27:1458-1486.
28. Karvestedt L, Martensson E, Grill V, Elofsson S, von Wendt G, Hamsten A, Brismar K. Peripheral sensory neuropathy associates with micro- or macroangiopathy: results from a population-based study of type 2 diabetic patients in Sweden. Diabetes Care 2009; 32:317-322.
29. Soper DS. A-priori sample size calculator for multiple regression [software]; 2014. http://www.danielsoper.com/statcalc.
30. Bracic M, Stefanovska A. Wavelet-based analysis of human blood-flow dynamics. Bull Math Biol 1998; 60:919-935.
31. Bakel AM, Zantinge EM. Neemt het aantal mensen met overgewicht toe of af? In Volksgezondheid Toekomst Verkenning, Nationaal Kompas Volksgezondheid. Bilthoven: RIVM, 〈http://www.nationaalkompas.nl〉 Nationaal Kompas Volksgezondheid\Determinanten\Persoonsgebonden\ Overgewicht, 25 September 2013.
32. Blokstra A, Bakel AM. Hoeveel mensen hebben een verhoogde bloeddruk? In Volksgezondheid Toekomst Verkenning, Nationaal Kompas Volksgezondheid. Bilthoven: RIVM, 〈http://www.nationaalkompas.nl〉 Nationaal Kompas Volksgezondheid\Determinanten\Persoonsgebon den\Bloeddruk, 7 December 2012.
33. Rossi M, Nannipieri M, Anselmino M, Pesce M, Muscelli E, Santoro G, Ferrannini E. Skin vasodilator function and vasomotion in patients with morbid obesity: effects of gastric bypass surgery. Obes Surg 2011; 21:87-94.
34. Tikhonova IV, Tankanag AV, Chemeris NK. Age-related changes of skin blood flow during postocclusive reactive hyperemia in human. Skin Res Technol 2013; 19:e174-e181.
35. Newman JM, Dwyer RM, St-Pierre P, Richards SM, Clark MG, Rattigan S. Decreased microvascular vasomotion and myogenic response in rat skeletal muscle in association with acute insulin resistance. J Physiol 2009; 587:2579-2588.
36. Bertuglia S, Colantuoni A, Coppini G, Intaglietta M. Hypoxia- or hyperoxia-induced changes in arteriolar vasomotion in skeletal muscle microcirculation. Am J Physiol 1991; 260:H362-H372.
37. Schmidt JA. Periodic hemodynamics in health and disease. Georgetown: R.G. Landes Company; 1996.
38. Branchet MC, Boisnic S, Frances C, Robert AM. Skin thickness changes in normal aging skin. Gerontology 1990; 36:28-35.
39. Sandby-Moller J, Poulsen T, Wulf HC. Epidermal thickness at different body sites: relationship to age, gender, pigmentation, blood content, skin type and smoking habits. Acta Derm Venereol 2003; 83:410-413.
40. Rucker M, Strobel O, Vollmar B, Roesken F, Menger MD. Vasomotion in critically perfused muscle protects adjacent tissues from capillary perfusion failure. Am J Physiol Heart Circ Physiol 2000; 279:H550-H558.
41. Ursino M, Colantuoni A, Bertuglia S. Vasomotion and blood flow regulation in hamster skeletal muscle microcirculation: A theoretical and experimental study. Microvasc Res 1998; 56:233-252.
42. Iwamoto Y, Maruhashi T, Fujii Y, Idei N, Fujimura N, Mikami S, et al. Intima-media thickness of brachial artery, vascular function, and cardiovascular risk factors. Arterioscler Thromb Vasc Biol 2012; 32:2295-2303.
43. IJzerman RG, de Jongh RT, Beijk MA, van Weissenbruch MM, Delemarre-van de Waal HA, Serne EH, Stehouwer CD. Individuals at increased coronary heart disease risk are characterized by an impaired microvascular function in skin. Eur J Clin Invest 2003; 33:536-542.
44. Kawasaki R, Tielsch JM, Wang JJ, Wong TY, Mitchell P, Tano Y, et al. The metabolic syndrome and retinal microvascular signs in a Japanese population: the Funagata study. Br J Ophthalmol 2008; 92:161-166.
45. Wong TY, Duncan BB, Golden SH, Klein R, Couper DJ, Klein BE, et al. Associations between the metabolic syndrome and retinal microvascular signs: the Atherosclerosis Risk In Communities study. Invest Ophthalmol Vis Sci 2004; 45:2949-2954.
46. Lang CH. Rates and tissue sites of noninsulin- and insulin-mediated glucose uptake in diabetic rats. Proc Soc Exp Biol Med 1992; 199:81-87.
47. Meijer RI, De Boer MP, Groen MR, Eringa EC, Rattigan S, Barrett EJ, et al. Insulin-induced microvascular recruitment in skin and muscle are related and both are associated with whole-body glucose uptake. Microcirculation 2012; 19:494-500.
48. Gronenschild EH, Muris DM, Schram MT, Karaca U, Stehouwer CD, Houben AJ. Semi-automatic assessment of skin capillary density: Proof of principle and validation. Microvasc Res 2013; 90:192-198.